The Next Generation of Energy: Why Many Consumers Are Waking Up to Their Power Quality Issues

 

A dropped Zoom call here. A brief internet outage there. When millions more Americans were working from their offices, it would’ve gone unnoticed. Now, with so many more working from home because of the coronavirus pandemic, people are waking up to their power quality issues.

“We didn’t really notice power quality issues, because we weren’t home,” said Joe Piccirilli, CEO of RoseWater Energy. “During the day, when we’re normally at work, is when our electrical system is taxed the most. Anything that went on in the home, there was nobody there to notice. Now, during the COVID era, for the last … 16 weeks to 20 weeks at this point, people have begun to notice.”

While the bulk of RoseWater’s focus has been on residential clients, more and more businesses are coming aboard as they enter a digital era in which they need documents instantly and can’t wait for a transition to a backup in the case of a power outage – something RoseWater’s product eliminates via battery technology always powering the inverter.

“We’ve noticed that now law offices, doctors’ offices – anybody who is storing digital information where secure, always available information has to be there – have become a great deal more interested in our product,” Piccirilli said. “Because our product guarantees perfect power. It is not just a battery backup. It is not something that just an enabler for a renewable. Our product guarantees that the power output of our device feeding your home is always perfect, regardless of input.”

That’s needed as the pandemic has more and more people working from home, something that most thought leaders agree will be more frequent even in a post-COVID world after the pandemic provided something of a proof of concept for many businesses. None of that works, however, if the devices we utilize don’t get the juice they need or get it in a good enough quality to make sure we can work our best.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More